Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: Lancet HIV. 2018 Nov 19;5(12):e688–e695. doi: 10.1016/S2352-3018(18)30316-3

Table 4:

Logistic regression analysis of variables associated with results of DNA PCR HIV testing at screening of HIV-exposed infants aged 4–12 weeks

Unweighted
MTCT frequency
Weighted
proportion (%)
Odds ratio
(95% CI)
p value Adjusted odds ratio
(95% CI)
p value

Mother’s reported timing of ART initiation
During this pregnancy 34/1081  3·4%(1·5–7·6)  2·5(0·5–11·9)  0·22  2·5(0·5–11·9)  0·22
Post partum  4/33 19·1%(4·6–53·5) 16·5(1·6–169·5)  0·0224 16·7(1·6–171·5)  0·0223
Stopped ART  2/17 10·2%(2·5–33·2)  8·0(1·3–50·3)  0·0305  8·5(1·6–45·4)  0·0171
Not on ART
 HIV-positive status known during  6/49  4·1%(1·3–12·5)  3·0(0·6–13·8)  0·15  3·0(0·7–13·5)  0·13
 pregnancy
 HIV-positive status unknown during 24/132 21·1%(12·3–33·9) 18·7(8·3–42·1) <0·0001 19·1(8·5–43·0) <0·0001
 pregnancy
Before this pregnancy 18/1148  1·4%(0·4–4·4)  1·00(ref)  ··  1·00(ref)  ··
Regional strata
Blantyre 20/551  3·3%(1·8–5·8)  1·2(0·5–2·7)  0·72  1·1(0·4–2·5)  0·90
South rural 21/635  3·5% (1·5–7·7)  1·2(0·4–3·5)  0·67  1·4(0·5–3·5)  0·47
Lilongwe 27/653  4·2%(3·3–5·3)  1·5(0·8–2·9)  0·21  1·4(0·7–2·8)  0·27
North-central rural 20/621  2·8%(1·6–5·1)  1·00(ref)  ··  1·00(ref)  ··

Analyses are based on 2460 mother–infant pairs; 18 had missing data for mother’s reported timing of ART initiation and 27 had missing data for known HIV-positive status during pregnancy. Mother’s reported timing of ART initiation and known HIV-positive status during pregnancy were combined into a single variable. Not on ART was split into known and unknown HIV-positive status during pregnancy. MTCT=mother-to-child transmission. ART=antiretroviral therapy.